Target intelligence / Profile preview

Malaria gametocyte

Molecular classification
Other (cellular stage; not a receptor, enzyme, transporter, or typical molecular class)
01

Overview

Malaria gametocytes are the specialized sexual blood-stage forms of Plasmodium parasites, produced during infection in human erythrocytes as a result of an irreversible differentiation process called gametocytogenesis[1][3][7]. Both male (microgametocyte) and female (macrogametocyte) gametocytes are formed and are essential for mosquito transmission, as they are the only life cycle stage infectious to the mosquito[1][5][3]. Gametocytes are functionally and morphologically distinct from asexual stages, exhibiting unique gene expression, organelle structures, and metabolic properties[2][4]. Upon ingestion by a mosquito, gametocytes mature into gametes, undergo fertilization, and contribute to parasite genetic diversity and continued transmission. Killing or blocking gametocytes is a critical step in malaria eradication efforts, making them a major therapeutic target, despite being a cell stage rather than a discrete molecular entity[5][7][3].

Other names
Malaria sexual blood stagePlasmodium gametocytegametocyte (of Plasmodium spp.)sexual stage (malaria)
02

Mechanism of action

Oxidative damage to gametocytes (e.g., by primaquine or methylene blue); Disruption of mitochondrial function; Inhibition of cellular maturation or developmental transition; Killing mature gametocytes, blocking their transmission

03

Biological functions

Sexual reproduction of PlasmodiumParasite transmission to mosquito vectorGamete formationGenetic diversity generation (via meiotic recombination in mosquitoes)
04

Disease associations

Infection (essential for malaria transmission)
05

Safety considerations

Haemolytic risk in patients with G6PD deficiency (notably with primaquine/tafenoquine)Limited therapeutic window; risk of resistance with monotherapyOff-target toxicity with transmission-blocking agents
06

Interacting drugs

Primaquine

4 more in the full profile.

07

Biomarkers

Detection of gametocyte-specific mRNAs (e.g., Pfs25 for female gametocytes)Gametocytemia (gametocyte levels in blood)Surface markers (e.g., Pfs16, Pfs25, Pfs230)

Beyond the preview

Go deeper on Malaria gametocyte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Malaria gametocyte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call